Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is APIXABAN, with a corresponding US DMF Number 29667.
Remarkably, this DMF maintains an Active status since its submission on September 02, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 18, 2015, and payment made on September 25, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II